Sartorius Relocates the Head Office of Its Biotechnology Subsidiary Vivascience to the Medical Park in Hanover, Germany
Executive Board of Vivascience AG
Dr. Ralf Hermann has been appointed as CEO and Chairman of the Executive Board of Vivascience AG. Aged 40, Mr. Hermann, whose full German title is Dr. rer. nat., holds a doctorate in the natural sciences and a university diploma in biology. Just before joining Vivascience, he last held a senior managerial position in marketing and business development at QIAGEN N.V. With his many years of experience in the international biotechnology market, Dr. Hermann will contribute his expertise to establish Vivascience successfully as one of the major suppliers in the proteomics field.
The company intends to include Mr. Keff and Mr. Krieg-Schneider in its Executive Board. Aged 35, Matthias Keff who is a business economist with a degree from a technical college, will assume the position of CFO. Just before joining Vivascience AG, he last held a senior managerial position in the controlling service unit at Juvena, which belongs to the Beiersdorf Group.
Dr. Frank Krieg-Schneider will be appointed to Vivascience AG’s Executive Board as CSO (Chief Scientific Officer). Aged 39, Mr. Krieg-Schneider, whose full German title is Dr. rer. nat., holds a doctorate in the natural sciences and a university diploma in biology. Before joining Vivascience’s Executive Board, he last held a senior managerial position in the R&D unit for molecular diagnostics at QIAGEN.
The Supervisory Board of Vivascience AG
The chairman of the Supervisory Board of Vivascience AG is Dr. Utz Claassen, Group CEO and Executive Board Chairman at Sartorius AG. Plans are that the Supervisory Board, which will consist of three members for the time being, will be extended in the short term to include six persons. Besides Dr. Claassen and Dr. Janssens, the President of the Biotechnology Division of the Sartorius Group, Vivascience AG’s Supervisory Board will include four members who do not belong to the Sartorius Group in order to include broad-based experience at the highest level.
It is anticipated that Dr. Jürgen Krumnow, member of the advisory group of the Deutsche Bank AG, will become the deputy chairman of the Supervisory Board.